BackOvation Science Overview

Ovation Science EBIT

Track Ovation Science's EBIT ($-630K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

-$167.20K
↓ 33.18% YoY

As of Jun 30, 2026

Annual EBIT (TTM)

-$632.30K
↓ 56.77% YoY

Trailing 12 months ending Jun 30, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Ovation Science (OVAT.CN) FAQ

The latest EBIT for OVAT.CN is $-630K as of June 2026. That compares with $-400K in the prior-year period — down 56.8% year over year. That is below the sector sector average of $2.5T. Investors often review this figure alongside Ovation Science's historical trend and sector peers before judging valuation or financial health.

Over the past year, OVAT.CN's EBIT moved from $-400K to $-630K — a 56.8% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Ovation Science's operating scale or balance-sheet position.

Against its sector companies, OVAT.CN currently prints $-630K for EBIT, while the sector average sits near $2.5T. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at Ovation Science's growth, margins, and balance sheet.

A EBIT figure of $-630K for OVAT.CN is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $2.5T. Explore the charts below for those layers of context.

After noting OVAT.CN's EBIT ($-630K), review year-over-year change from $-400K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.